lobbying_activities: 253732

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
253732	a72a19d5-6f7f-40aa-829c-7ff222eb44dc	YY	D. LYNN JOHNSON	86653	KING PHARMACEUTICALS INC	2003	year_end	PHA	Asked a Senate office to contact the FDA to determine why the agency would not agree to King Pharmaceuticals' promoting the use of AtroPen (approved by the FDA) with physicians and the public by using FDA approved informational materials.	HOUSE OF REPRESENTATIVES,SENATE	40000		0	0	2004-01-06T00:00:00-05:00